Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
DRI Conducts Search at Cipla's Mumbai Office and Depot Over Imported Drugs

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

DRI Conducts Search at Cipla's Mumbai Office and Depot Over Imported Drugs

Analysed 17 Nov 2026·2 sources analysed·Bhiwandi, India·Business
DRI Conducts Search at Cipla's Mumbai Office and Depot Over Imported DrugsPreviousNext

The Directorate of Revenue Intelligence (DRI) Mumbai unit searched Cipla's office in Vikhroli and its depot in Bhiwandi over the classification or exemption of an imported pharmaceutical finished product. Cipla stated it cooperated fully with authorities and that the search would not materially affect its financials or operations. The search was conducted under Section 105 of the Customs Act, 1962. Cipla's shares traded slightly lower following the news.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 42/100.

Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 17 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 17 Nov, 06:31 am. Other outlets followed.

17 Nov, 06:31 am2 sources · 2 h17 Nov, 08:16 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Rediff.com India Files Draft Papers for Rs 600 Crore IPO to Fund Digital Expansion
Next →
Highway Infrastructure Shares Rise on Strong Orders, Fundraise, and Q2 Earnings
news1817 Nov, 06:31 am
DRI searches Cipla's Mumbai office, Bhiwandi depot over imported drugs
  • 2
    economictimes17 Nov, 08:16 am
    DRI searches Cipla's Mumbai office, Bhiwandi depot over imported drugs
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Directorate of Revenue Intelligence Mumbai zonal unitDirectorate of Revenue IntelligenceSecurities and Exchange Board of India
    Corporate
    Cipla Limited
    Enforcement
    Directorate of Revenue Intelligence

    Story context

    Category
    Business
    Location
    Bhiwandi, India
    Sources analysed
    2
    Last analysed
    17 Nov 2026
    Key entities
    BhiwandiMumbaiDirectorate of Revenue IntelligenceVikhroliCiplaNew DelhiThaneSecurities and Exchange Board of IndiaBombay Stock ExchangeIndian rupeePress Trust of India